Double-Blind, Placebo-Controlled Multi-Center Trial Of Baclofen For The Treatment Of Cocaine Dependence
To assess the efficacy and safety of baclofen in reducing cocaine use in subjects with cocaine dependence. It is hypothesized that baclofen treatment, compared to placebo, will be associated with fewer days of cocaine use as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).
May 07, 2018
The primary objective of this study is to assess the efficacy of baclofen in reducing cocaine use in subjects with cocaine dependence (DSM-IV criteria). The hypothesis is that baclofen will reduce cocaine use over the treatment period as compared to placebo as determined by selfreport confirmed with urine assays for BE.
Please note that the supplementary documents may not be fully Section 508 compliant. Please contact us for assistance.